Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease
NCT04926272
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
18F-92
Sponsor
First Affiliated Hospital of Fujian Medical University